John Deadman

1.3k total citations
67 papers, 1.0k citations indexed

About

John Deadman is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, John Deadman has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 29 papers in Organic Chemistry and 17 papers in Infectious Diseases. Recurrent topics in John Deadman's work include Chemical Synthesis and Analysis (24 papers), HIV/AIDS drug development and treatment (16 papers) and Peptidase Inhibition and Analysis (14 papers). John Deadman is often cited by papers focused on Chemical Synthesis and Analysis (24 papers), HIV/AIDS drug development and treatment (16 papers) and Peptidase Inhibition and Analysis (14 papers). John Deadman collaborates with scholars based in United Kingdom, Australia and China. John Deadman's co-authors include David I. Rhodes, Vijay V. Kakkar, Geeta Patel, Said Elgendy, Jonathan A. Coates, Göran Claeson, Christopher A. Goodwin, Michael Scully, Jehan A. Baban and Janet Newman and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

John Deadman

66 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Deadman United Kingdom	21	508	437	216	170	139	67	1.0k
Christopher Pargellis United States	10	844 1.7×	300 0.7×	171 0.8×	143 0.8×	70 0.5×	12	1.2k
J.P. Guilloteau France	13	652 1.3×	156 0.4×	195 0.9×	162 1.0×	100 0.7×	17	1.0k
Joseph W. Leone United States	17	888 1.7×	134 0.3×	134 0.6×	112 0.7×	104 0.7×	38	1.5k
Susan Pav United States	12	960 1.9×	344 0.8×	115 0.5×	97 0.6×	78 0.6×	16	1.4k
E. Sudbeck United States	22	396 0.8×	514 1.2×	310 1.4×	230 1.4×	57 0.4×	36	1.3k
S. Maignan France	12	786 1.5×	160 0.4×	184 0.9×	164 1.0×	105 0.8×	13	1.2k
Robert Zahler United States	25	680 1.3×	834 1.9×	352 1.6×	130 0.8×	32 0.2×	49	1.8k
Guido Bold Switzerland	25	907 1.8×	758 1.7×	132 0.6×	86 0.5×	131 0.9×	46	1.8k
Stephen F. Brady United States	17	756 1.5×	449 1.0×	194 0.9×	185 1.1×	53 0.4×	26	1.2k
Tai‐Shun Lin United States	24	1.1k 2.1×	455 1.0×	548 2.5×	212 1.2×	254 1.8×	51	2.0k

Countries citing papers authored by John Deadman

Since Specialization

Citations

This map shows the geographic impact of John Deadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Deadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Deadman more than expected).

Fields of papers citing papers by John Deadman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Deadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Deadman. The network helps show where John Deadman may publish in the future.

Co-authorship network of co-authors of John Deadman

This figure shows the co-authorship network connecting the top 25 collaborators of John Deadman. A scholar is included among the top collaborators of John Deadman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Deadman. John Deadman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ryan, John H., Roger J. Mulder, Craig L. Francis, et al.. (2015). Unexpected Isomerisation of a Fragment Analogue During Fragment-Based Screening of HIV Integrase Catalytic Core Domain. Australian Journal of Chemistry. 68(12). 1871–1879. 1 indexed citations

Peat, Thomas S., Olan Dolezal, Janet Newman, David L. Mobley, & John Deadman. (2014). Interrogating HIV integrase for compounds that bind- a SAMPL challenge. Journal of Computer-Aided Molecular Design. 28(4). 347–362. 23 indexed citations

Robertson, Mark J., John B. Bremner, Jonathan A. Coates, et al.. (2011). Synthesis and antibacterial activity of C2-symmetric binaphthyl scaffolded amino acid derivatives. European Journal of Medicinal Chemistry. 46(9). 4201–4211. 8 indexed citations

Rhodes, David I., Thomas S. Peat, Nick Vandegraaff, et al.. (2011). Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site. ChemBioChem. 12(15). 2311–2315. 29 indexed citations

Bremner, John B., Paul A. Keller, Stephen G. Pyne, et al.. (2011). Synthesis and antibacterial activity of some binaphthyl-supported macrocycles containing a cationic amino acid. Bioorganic & Medicinal Chemistry. 19(11). 3549–3557. 3 indexed citations

Wielens, J., Stephen J. Headey, John Deadman, et al.. (2010). Fragment‐Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus 1. ChemMedChem. 6(2). 258–261. 23 indexed citations

Bremner, John B., Paul A. Keller, Stephen G. Pyne, et al.. (2010). Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1. Bioorganic & Medicinal Chemistry. 18(7). 2611–2620. 19 indexed citations

Li, Ben, E. D. Jones, Li Chen, et al.. (2010). Studies on the structure–activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents. Bioorganic & Medicinal Chemistry Letters. 20(17). 5334–5336. 6 indexed citations

Vandegraaff, Nick, David I. Rhodes, E. D. Jones, et al.. (2010). Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses. Bioorganic & Medicinal Chemistry Letters. 20(17). 5013–5018. 16 indexed citations

10.

Wielens, J., Stephen J. Headey, David I. Rhodes, et al.. (2010). Crystal structure of the HIV‐1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site. FEBS Letters. 584(8). 1455–1462. 31 indexed citations

11.

Bremner, John B., Paul A. Keller, Stephen G. Pyne, et al.. (2010). Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 2. Bioorganic & Medicinal Chemistry. 18(13). 4793–4800. 12 indexed citations

12.

Bremner, John B., Jonathan A. Coates, John Deadman, et al.. (2009). Binaphthyl scaffolded peptoids via ring-closing metathesis reactions and their anti-bacterial activities. Bioorganic & Medicinal Chemistry Letters. 19(11). 3010–3013. 14 indexed citations

13.

Bremner, John B., et al.. (2008). Synthesis of novel N-protected hydrophobic phenylalanines and their application in potential antibacterials. European Journal of Medicinal Chemistry. 44(3). 1001–1009. 13 indexed citations

14.

Skordalakes, Emmanuel, Guy Dodson, Michael Scully, et al.. (2001). Inhibition of human α-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate 1 1Edited by R. Huber. Journal of Molecular Biology. 311(3). 549–555. 33 indexed citations

15.

Patel, Geeta, et al.. (1999). A cyclic peptide analogue of the loop III region of platelet‐derived growth factor‐BB is a synthetic antigen for the native protein. Journal of Peptide Research. 53(1). 68–74. 6 indexed citations

16.

Skordalakes, Emmanuel, Said Elgendy, Christopher A. Goodwin, et al.. (1998). Bifunctional Peptide Boronate Inhibitors of Thrombin: Crystallographic Analysis of Inhibition Enhanced by Linkage to an Exosite 1 Binding Peptide. Biochemistry. 37(41). 14420–14427. 16 indexed citations

17.

Goodwin, Christopher A., John Deadman, Bernard Le Bonniec, et al.. (1996). Heparin enhances the catalytic activity of des-ETW-thrombin. Biochemical Journal. 315(1). 77–83. 2 indexed citations

18.

Deadman, John, Göran Claeson, & Michael Scully. (1995). Structure/Function Aspects of Neutral P1 Residue Peptide Inhibitors of Thrombin. Journal of enzyme inhibition. 9(1). 29–41. 11 indexed citations

19.

Goodwin, Christopher A., Caroline Wheeler‐Jones, V V Kakkar, et al.. (1994). Thrombin Receptor-Activating Peptide Does Not Stimulate Platelet Procoagulant Activity. Biochemical and Biophysical Research Communications. 202(1). 321–327. 19 indexed citations

20.

Elgendy, Said, John Deadman, & Göran Claeson. (1993). New Peptide Boronic Acid Inhibitors of Thrombin. Advances in experimental medicine and biology. 340. 173–178. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact